Mona N. Rahman, Ph.D. - Publications

Affiliations: 
2001 Queen's University, Canada, Kingston, Ontario, Canada 
Area:
Biochemistry

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Rahman MN, Vukomanovic D, Vlahakis JZ, Szarek WA, Nakatsu K, Jia Z. Structural Insights into Azole-based Inhibitors of Heme Oxygenase-1: Development of Selective Compounds for Therapeutic Applications. Current Medicinal Chemistry. PMID 30674243 DOI: 10.2174/0929867325666180606082512  0.397
2017 Lee MJY, Wang Y, Jiang Y, Li X, Ma J, Tan H, Turner-Wood K, Rahman MN, Chen G, Jia Z. Function Coupling Mechanism of PhuS and HemO in Heme Degradation. Scientific Reports. 7: 11273. PMID 28900278 DOI: 10.1038/S41598-017-11907-5  0.312
2016 Vukomanovic D, Rahman MN, Maines MD, Ozolinš TR, Szarek WA, Jia Z, Nakatsu K. Cysteine-independent activation/inhibition of heme oxygenase-2. Medical Gas Research. 6: 10-13. PMID 27826418 DOI: 10.4103/2045-9912.179341  0.455
2014 Vukomanovic D, Rahman MN, Bilokin Y, Golub AG, Brien JF, Szarek WA, Jia Z, Nakatsu K. In vitro Activation of heme oxygenase-2 by menadione and its analogs. Medical Gas Research. 4: 4. PMID 24533775 DOI: 10.1186/2045-9912-4-4  0.315
2014 Rahman M, Vukomanovic D, Vlahakis J, Szarek W, Nakatsu K, Jia Z. Structural insights into heme oxygenase-1 inhibition by azole-based compounds Acta Crystallographica Section a Foundations and Advances. 70: C831-C831. DOI: 10.1107/S2053273314091682  0.479
2013 Ye Q, Feng Y, Yin Y, Faucher F, Currie MA, Rahman MN, Jin J, Li S, Wei Q, Jia Z. Structural basis of calcineurin activation by calmodulin. Cellular Signalling. 25: 2661-7. PMID 24018048 DOI: 10.1016/J.Cellsig.2013.08.033  0.388
2013 Rahman MN, Vukomanovic D, Vlahakis JZ, Szarek WA, Nakatsu K, Jia Z. Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds. J R Soc Interface. 10: 20120697. PMID 23097500 DOI: 10.1098/Rsif.2012.0697  0.414
2012 Singh VK, Rahman MN, Munro K, Uversky VN, Smith SP, Jia Z. Free cysteine modulates the conformation of human C/EBP homologous protein. Plos One. 7: e34680. PMID 22496840 DOI: 10.1371/Journal.Pone.0034680  0.315
2012 Rahman MN, Vlahakis JZ, Vukomanovic D, Lee W, Szarek WA, Nakatsu K, Jia Z. A novel, "double-clamp" binding mode for human heme oxygenase-1 inhibition. Plos One. 7: e29514. PMID 22276118 DOI: 10.1371/Journal.Pone.0029514  0.446
2011 Vukomanovic D, McLaughlin BE, Rahman MN, Szarek WA, Brien JF, Jia Z, Nakatsu K. Selective activation of heme oxygenase-2 by menadione. Canadian Journal of Physiology and Pharmacology. PMID 22039914 DOI: 10.1139/Y11-091  0.325
2010 Roman G, Rahman MN, Vukomanovic D, Jia Z, Nakatsu K, Szarek WA. Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone. Chemical Biology & Drug Design. 75: 68-90. PMID 19954435 DOI: 10.1111/J.1747-0285.2009.00909.X  0.387
2010 Rahman MN, Vlahakis JZ, Roman G, Vukomanovic D, Szarek WA, Nakatsu K, Jia Z. Structural characterization of human heme oxygenase-1 in complex with azole-based inhibitors. Journal of Inorganic Biochemistry. 104: 324-30. PMID 19917515 DOI: 10.1016/J.Jinorgbio.2009.10.011  0.438
2009 Rahman MN, Vlahakis JZ, Vukomanovic D, Szarek WA, Nakatsu K, Jia Z. X-ray crystal structure of human heme oxygenase-1 with (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4[((5-trifluoromethylpyridin-2-yl)thio)methyl]-1,3-dioxolane: a novel, inducible binding mode. Journal of Medicinal Chemistry. 52: 4946-50. PMID 19601578 DOI: 10.1021/Jm900434F  0.413
2009 Vlahakis JZ, Hum M, Rahman MN, Jia Z, Nakatsu K, Szarek WA. Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring. Bioorganic & Medicinal Chemistry. 17: 2461-75. PMID 19268600 DOI: 10.1016/J.Bmc.2009.01.078  0.304
2008 Rahman MN, Vlahakis JZ, Szarek WA, Nakatsu K, Jia Z. X-ray crystal structure of human heme oxygenase-1 in complex with 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors. Journal of Medicinal Chemistry. 51: 5943-52. PMID 18798608 DOI: 10.1021/Jm800505M  0.505
2003 Hill BC, Becker L, Anand V, Kusmierczyk A, Marcovina SM, Rahman MN, Gabel BR, Jia Z, Boffa MB, Koschinsky ML. A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidation. Archives of Biochemistry and Biophysics. 412: 186-95. PMID 12667482 DOI: 10.1016/S0003-9861(03)00032-8  0.637
2002 Rahman MN, Becker L, Petrounevitch V, Hill BC, Jia Z, Koschinsky ML. Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10. Biochemistry. 41: 1149-55. PMID 11802713 DOI: 10.1021/Bi010964I  0.665
2002 Schneider M, Boffa M, Stewart R, Rahman M, Koschinsky M, Nesheim M. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme. The Journal of Biological Chemistry. 277: 1021-30. PMID 11684677 DOI: 10.1074/Jbc.M104444200  0.507
2001 Rahman MN, Petrounevitch V, Jia Z, Koschinsky ML. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding. Protein Engineering. 14: 427-38. PMID 11477223 DOI: 10.1093/Protein/14.6.427  0.655
2001 Ye Q, Rahman MN, Koschinsky ML, Jia Z. High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: insights into ligand binding. Protein Science : a Publication of the Protein Society. 10: 1124-9. PMID 11369850 DOI: 10.1110/Ps.01701  0.65
1998 Rahman M, Jia Z, Gabel BR, Marcovina SM, Koschinsky ML. Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100. Protein Engineering. 11: 1249-56. PMID 9930675 DOI: 10.1093/Protein/11.12.1249  0.644
Show low-probability matches.